SEC Form 4 · accession 0001209191-17-066627
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry D Quart
Officer — Chief Executive Officer · Director
Period of report
Dec 18, 2017
Accepted (ET)
Dec 20, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 28, 2017 | J | 1,684 | $12.6225 | A | 67,993 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $17.00 | Dec 18, 2017 | A | 310,000 | A | — | Dec 18, 2027 | Common Stock | 310,000 | 310,000 | D |
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 28,2017.
- F2The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the Date of Grant.